|
- 2018
Dapsone in the Treatment of Epidermolysis Bullosa Acquisita Long - Term Follow - Up SciDoc Publishers | Open Access | Science Journals | Media PartnersDOI: http://dx.doi.org/10.19070/2332-2977-1600026 Keywords: n/a Abstract: Epidermolysis bullosa acquisita (EBA) is a rare, acquired, chronic subepidermal bullous disease of the skin and mucosa characterized by autoantibodies to type VII collagen structures, a major component of anchoring fibrils, that attach the epidermis onto the dermis. The treatment of EBA is based on anecdotal reports in the literature with systemic therapies. We report a case of EBA successfully treated by dapsone
|